Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins.
about
Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence.Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene.In vitro analyses of mild heat stress in combination with antifungal agents against Aspergillus fumigatus biofilm.Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009.Breakthrough filamentous fungal infections in pediatric hematopoetic stem cell transplant and oncology patients receiving caspofungin.Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing.Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network.Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methodsTrends in antifungal susceptibility testing using CLSI reference and commercial methods.New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.In vitro susceptibility testing in Aspergillus species: an update.Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection.Epidemiology and antifungal resistance in invasive Aspergillosis according to primary disease: review of the literature.Caspofungin: when and how? The microbiologist's view.ECIL-3 classical diagnostic procedures for the diagnosis of invasive fungal diseases in patients with leukaemia.Invasive aspergillosis: resistance to antifungal drugs.Echinocandins: production and applications.The evolving role of antifungal susceptibility testing.Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management.Medically important fungi respond to azole drugs: an update.Caspofungin: Pharmacodynamics, pharmacokinetics, clinical uses and treatment outcomes.Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus.Echinocandins in antifungal pharmacotherapy.The MAP kinase MpkA controls cell wall integrity, oxidative stress response, gliotoxin production and iron adaptation in Aspergillus fumigatus.Animal Models for Studying Triazole Resistance in Aspergillus fumigatus.Comparative Evaluation of Sensititre YeastOne and CLSI M38-A2 Reference Method for Antifungal Susceptibility Testing of Aspergillus spp. against Echinocandins.Experimental efficacy of anidulafungin against Aspergillus terreus species complex.Comparison of assessment of oxygen consumption, Etest, and CLSI M38-A2 broth microdilution methods for evaluation of the susceptibility of Aspergillus fumigatus to posaconazole.Interaction of platelets and anidulafungin against Aspergillus fumigatus.Fungal echinocandin resistance.In vitro activity and in vivo efficacy of anidulafungin in murine infections by Aspergillus flavus.In vitro activity of a new oral glucan synthase inhibitor (MK-3118) tested against Aspergillus spp. by CLSI and EUCAST broth microdilution methodsWild-type MIC distributions and epidemiological cutoff values for caspofungin and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).Comparative Evaluation of Disc Diffusion and E-test with Broth Micro-dilution in Susceptibility testing of Amphotericin B, Voriconazole and Caspofungin against Clinical Aspergillus isolates.In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution method.Comparison of anidulafungin MICs determined by the clinical and laboratory standards institute broth microdilution method (M27-A3 document) and Etest for Candida species isolates.Acremonium keratomycosis in a cat.The echinocandin B producer fungus Aspergillus nidulans var. roseus ATCC 58397 does not possess innate resistance against its lipopeptide antimycotic.Antifungal Susceptibility Testing of Fusarium: A Practical Approach.Azole-Resistant Invasive Aspergillosis: Relationship to Agriculture
P2860
Q33559702-540E8642-5D15-4382-A03F-357E304E5D71Q33613758-4F5C3061-87E9-4808-9634-9B249448F279Q35068517-136FAC5C-29E9-4796-A6C7-4E27E8E5B9BAQ35848799-5500FBA3-3922-4B36-B6F3-EC2BB41FAB15Q36684261-36ADF7BA-067F-4BFF-A9A8-431B4CE97DFEQ37115801-0B6FD16D-642D-4795-9A48-A761C59E5AB4Q37374804-BD566A05-ACD7-4F79-9DF6-47CC787ADAA5Q37374949-543282F7-B524-4964-97D7-FB19FF88056EQ37557695-E9C86EDA-A2C8-4311-85D9-8A3F3812DCF9Q37608276-8EFF491E-D197-46A1-8517-18C936664F6AQ37742178-6127B94C-3B7C-4D98-B2EE-73EDE0CC2413Q37783285-3377982E-A044-4C6E-A2E3-6106C907285DQ37864427-8E35D4AF-0A94-4D17-821E-FE2415E031E8Q37888750-878F0772-07C7-4530-A883-70D6B3D7FED7Q37974519-0F476550-9C56-41B8-B9F9-5D3277DC5DADQ37983464-058DAC3B-FC34-406E-9D0C-2400865B8387Q38086769-5C97FE0B-5A6A-4A09-AD23-7F1720905420Q38095809-207B6F61-6D74-4250-941E-0C027998D4A5Q38254290-608C61E7-A789-49B2-9B1F-E45FD7828468Q38559208-BAAD26D3-5F52-417D-8AE7-D9CB533A20FDQ38586680-D0F8AEBA-9733-44FD-9788-55D5CCC92EFAQ38711698-C1A89CB7-1635-4DC0-97CF-43F9E9273DC2Q39458862-5F262C31-FE05-4D27-91FF-341FF39C3432Q39568535-E753871D-CCAA-4A78-A16B-B7C0CDE4E1A5Q40045642-5515A242-A351-423B-9652-259AAB45C5FEQ40283086-8AF71A5D-1AB8-48F5-A9D1-3DA0E81DB825Q41226559-DB793400-3C62-4CD5-A55A-F4F2531B0C10Q41788151-E0EB585B-5726-44C1-80FF-7DCDD532D010Q41842360-A995F1FC-BB4E-42BB-92D9-2688F887608FQ41848811-85753807-40AD-470F-9589-094BDCD4C822Q41857220-3B2047B6-1EE8-444D-9964-E0D2F848FEF5Q42076268-67F618C7-E810-4DD4-A1A5-5ADC65887EE9Q42116260-8BC9066A-C81C-4577-9DCD-D3DB9DE87523Q42191165-95696A07-3A22-4B63-A0CC-16B1D67733C0Q42576501-CD86DB5B-B221-4047-8105-122950BF2A37Q42910172-1008F924-C49C-46DA-A2CE-4854FCDF3541Q44969234-6E5CF486-4E91-464C-9B15-6055398AA2DFQ47812501-3A1D5C0F-833A-47F3-84D0-0060CAA41590Q49247381-5C3B0978-8417-45CA-8A25-007E4D26574DQ57650487-23F3E17B-1AED-445D-9EEC-A75F1AC32E71
P2860
Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Establishing in vitro-in vivo ...... f azoles versus echinocandins.
@en
Establishing in vitro-in vivo ...... f azoles versus echinocandins.
@nl
type
label
Establishing in vitro-in vivo ...... f azoles versus echinocandins.
@en
Establishing in vitro-in vivo ...... f azoles versus echinocandins.
@nl
prefLabel
Establishing in vitro-in vivo ...... f azoles versus echinocandins.
@en
Establishing in vitro-in vivo ...... f azoles versus echinocandins.
@nl
P2093
P2860
P50
P921
P356
P1476
Establishing in vitro-in vivo ...... of azoles versus echinocandins
@en
P2093
Aimanianda Vishukumar
David Perlin
Guillermo Garcia-Effron
P2860
P304
P356
10.1128/AAC.00190-08
P407
P577
2008-07-21T00:00:00Z